Article info

Download PDFPDF

Feasibility of combined screening for upper gastrointestinal adenocarcinoma risk by serology and Cytosponge testing: the SUGAR study

Authors

  1. Correspondence to Dr Jan Bornschein, Translational Gastroenterology Unit, John Radcliffe Hospital, Oxford University Hospitals, Headley Way, Oxford OX3 9DU, UK; jan.bornschein{at}ouh.nhs.uk
View Full Text

Citation

Xu Y, Miremadi A, Link A, et al
Feasibility of combined screening for upper gastrointestinal adenocarcinoma risk by serology and Cytosponge testing: the SUGAR study

Publication history

  • Received January 2, 2019
  • Accepted May 18, 2019
  • First published June 24, 2019.
Online issue publication 
November 20, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.